Tower Research Capital LLC (Trc) Artivion, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Artivion, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,404 shares of AORT stock, worth $64,162. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,404
Previous 5,410
74.05%
Holding current value
$64,162
Previous $168,000
64.88%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding AORT
# of Institutions
224Shares Held
39.8MCall Options Held
23.3KPut Options Held
0-
Black Rock Inc. New York, NY6.64MShares$303 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.03MShares$138 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.48MShares$114 Million0.13% of portfolio
-
Morgan Stanley New York, NY2.24MShares$102 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY2.02MShares$92.3 Million0.19% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.84B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...